Navicixizumab
Navicixizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Navicixizumab is under investigation in clinical trial NCT02298387 (A Phase 1 Study of Navicixizumab in Subjects With Solid Tumors).
| Trade Name | Navicixizumab |
| Generic | Navicixizumab |
| Navicixizumab Other Names | Navicixizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Navicixizumab
